Page last updated: 2024-08-24

irinotecan and Sarcoma, Small Cell

irinotecan has been researched along with Sarcoma, Small Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arcamone, G; Bisogno, G; Carli, M; Miglionico, L; Riccardi, R; Scagnellato, A1
Brandsma, D; De Jong, FA; Hamberg, P; Sleijfer, S; Verweij, J1

Reviews

1 review(s) available for irinotecan and Sarcoma, Small Cell

ArticleYear
Irinotecan-induced central nervous system toxicity. Report on two cases and review of the literature.
    Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Agents, Phytogenic; Ataxia; Camptothecin; Capecitabine; Central Nervous System; Colorectal Neoplasms; Cytotoxins; Deoxycytidine; Dexamethasone; Dysarthria; Female; Fluorouracil; Granisetron; Humans; Irinotecan; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Sarcoma, Small Cell; Serotonin Antagonists; Topoisomerase I Inhibitors

2008

Other Studies

1 other study(ies) available for irinotecan and Sarcoma, Small Cell

ArticleYear
No effect of irinotecan in patients with resistant desmoplastic small round cell tumor.
    Pediatric blood & cancer, 2010, Volume: 54, Issue:1

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Camptothecin; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Fibroma, Desmoplastic; Humans; Irinotecan; Male; Prognosis; Sarcoma, Small Cell

2010